A step forward in research on psychotherapy of schizophrenia.
The Boston group have devoted 10 years to a thoughtful, comprehensive, and much needed study that will undoubtedly become a classic reference in the field. If the emphasis is placed on differences that reached statistical significance, the major finding is minimal outcome differences between exploratory, insight-oriented (EIO) and reality-adaptive, supportive (RAS) therapies with, if anything, significant advantages to RAS in recidivism and performance. Selective beneficial effects for EIO gain only very weak support. The results should contribute to a climate wherein we may move on to study how psychotherapy and pharmacotherapy can be combined to achieve optimal results and minimize toxic effects.
D002986:Clinical Trials as Topic; D005500:Follow-Up Studies; D006801:Humans; D011575:Psychoanalytic Therapy / Q000379:methods*; D011937:Reality Therapy; D012106:Research; D012559:Schizophrenia / Q000628:therapy*; D012565:Schizophrenic Psychology; D012917:Social Adjustment